US stock · US markets · public data

MRNA

Moderna Inc · Healthcare

Reference price$223.75Updated according to the public source
P/E—
P/B13.20
ROE-39.00%
DY 12M0.00%
Net margin—
Net debt/equity—
Market capUS$ 89.3 B
Volume (shares)10,389,550
SectorHealthcare
Overview

About MRNA

Demonstrações públicas consolidadas + SEC Company Facts

Moderna Inc (MRNA) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data

The source returned no recent distributions for this asset.

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$6,848,000,000.00$3,236,000,000.00$1,944,000,000.00—
Operating Income-$4,239,000,000.00-$3,945,000,000.00-$3,074,000,000.00—
Net Income-$4,714,000,000.00-$3,561,000,000.00-$2,822,000,000.00—
EPS Diluted-$12.33 / share-$9.28 / share-$7.26 / share—

Balance sheet

Account2023202420252026
Total Assets$18,426,000,000.00$14,142,000,000.00$12,338,000,000.00—
Total Liabilities$4,572,000,000.00$3,241,000,000.00$3,688,000,000.00—
Total Equity$13,854,000,000.00$10,901,000,000.00$8,650,000,000.00—
Long-term Debt—$0.00$590,000,000.00—
Shares Outstanding386,339,594 shares382,073,208 shares385,815,877 shares394,939,424 shares
Cash & Investments$2,907,000,000.00$1,927,000,000.00$2,595,000,000.00—
Dívida Líquida—-$1,927,000,000.00-$2,005,000,000.00—

Cash flow

Account2023202420252026
Operating Cash Flow-$3,118,000,000.00-$3,004,000,000.00-$1,873,000,000.00—
Capital Expenditures$707,000,000.00$1,051,000,000.00$192,000,000.00—
Free Cash Flow-$3,825,000,000.00-$4,055,000,000.00-$2,065,000,000.00—
FAQ

Frequently asked questions

What is the price of MRNA?

The reference price available for MRNA is $223.75.

What is the P/B of MRNA?

The P/B of MRNA is 13.20. This compares price with reported book value per share.

What is the ROE of MRNA?

The ROE (Return on Equity) of MRNA is -39.00%. This relates the reported net result to shareholders' equity.

What is the dividend yield of MRNA?

The dividend yield of MRNA is 0.00%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of MRNA?

The market capitalization of MRNA is US$ 89.3 B.

What sector is MRNA in?

MRNA operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.